Use of Aspirin Associates with Longer Primary Patency of Hemodialysis Grafts

Extended-release dipyridamole plus low-dose aspirin (ERDP/ASA) prolongs primary unassisted graft patency of newly created hemodialysis arteriovenous grafts, but the individual contributions of each component are unknown. Here, we analyzed whether use of aspirin at baseline associated with primary un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dixon, Bradley S., Beck, Gerald J., Dember, Laura M., Vazquez, Miguel A., Greenberg, Arthur, Delmez, James A., Allon, Michael, Himmelfarb, Jonathan, Hu, Bo, Greene, Tom, Radeva, Milena K., Davidson, Ingemar J., Ikizler, T. Alp, Braden, Gregory L., Lawson, Jeffrey H., Cotton, James R., Kusek, John W., Feldman, Harold I.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2011
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065232/
https://ncbi.nlm.nih.gov/pubmed/21415156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010060582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados